ClinVar Miner

Submissions for variant NM_000546.6(TP53):c.1101-83_1106del

dbSNP: rs1597345782
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001017307 SCV001178372 uncertain significance Hereditary cancer-predisposing syndrome 2019-02-12 criteria provided, single submitter clinical testing The c.1101-83_1106del89 alteration, spans intron 9 through coding exon 10 of the TP53 gene, results from a deletion of 89 nucleotides at positions c.1101-83 to c.1106, causing a deletion of the native splice acceptor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay however, this deletion occurs at the 3' terminus of TP53 , is not expected to trigger nonsense-mediated mRNA decay, and impacts only the last exon of the protein. The exact functional impact of the deleted exon is unknown at this time. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.